Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression.

× No keyword cloud information.

33 in total

1. Can the detection of misery perfusion in chronic cerebrovascular disease be based on reductions in baseline CBF and vasoreactivity?

Authors: Hidehiko Okazawa; Tatsuro Tsuchida; Masato Kobayashi; Yoshikazu Arai; Marco Pagani; Makoto Isozaki; Yoshiharu Yonekura
Journal: Eur J Nucl Med Mol Imaging Date: 2006-08-08 Impact factor: 9.236

2. Low-dose acetazolamide reduces CO(2)-O(2) stimulus interaction within the peripheral chemoreceptors in the anaesthetised cat.

Authors: L J Teppema; A Dahan; C N Olievier
Journal: J Physiol Date: 2001-11-15 Impact factor: 5.182

Review 3. New insights into carbonic anhydrase inhibition, vasodilation, and treatment of hypertensive-related diseases.

Authors: Erik R Swenson
Journal: Curr Hypertens Rep Date: 2014-09 Impact factor: 5.369

4. Effect of acetazolamide on pulmonary and muscle gas exchange during normoxic and hypoxic exercise.

Authors: Amy M Jonk; Irene P van den Berg; I Mark Olfert; D Walter Wray; Tatsuya Arai; Susan R Hopkins; Peter D Wagner
Journal: J Physiol Date: 2007-01-11 Impact factor: 5.182

5. Effects of acetazolamide on cerebrovascular function and breathing stability at 5050 m.

Authors: Jui-Lin Fan; Keith R Burgess; Kate N Thomas; Samuel J E Lucas; James D Cotter; Bengt Kayser; Karen C Peebles; Philip N Ainslie
Journal: J Physiol Date: 2012-01-04 Impact factor: 5.182

6. Effectiveness of acetazolamide for reversal of metabolic alkalosis in weaning COPD patients from mechanical ventilation.

Authors: Christophe Faisy; Amel Mokline; Olivier Sanchez; Jean-Marc Tadié; Jean-Yves Fagon
Journal: Intensive Care Med Date: 2010-03-09 Impact factor: 17.440

Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression.

1. Can the detection of misery perfusion in chronic cerebrovascular disease be based on reductions in baseline CBF and vasoreactivity?

2. Low-dose acetazolamide reduces CO(2)-O(2) stimulus interaction within the peripheral chemoreceptors in the anaesthetised cat.

Review 3. New insights into carbonic anhydrase inhibition, vasodilation, and treatment of hypertensive-related diseases.

4. Effect of acetazolamide on pulmonary and muscle gas exchange during normoxic and hypoxic exercise.

5. Effects of acetazolamide on cerebrovascular function and breathing stability at 5050 m.

6. Effectiveness of acetazolamide for reversal of metabolic alkalosis in weaning COPD patients from mechanical ventilation.

7. Effects of low-dose acetazolamide on exercise performance in simulated altitude.

8. Acetazolamide pre-treatment before ascending to high altitudes: when to start?

9. Obesity hypoventilation syndrome.

Review 10. Acetazolamide: a second wind for a respiratory stimulant in the intensive care unit?